Categories: Research

A new analysis of dozens of animal studies evaluating the effects of the cholesterol-lowering statin class of drugs on atherosclerosis found larger positive effects in studies not sponsored by the pharmaceutical industry as compared to those that were industry sponsored.

Studies of whether patients are taking a blood thinner as prescribed, whether antibiotic treatment of cancer patients’ fevers matches guidelines, and whether one form of a leading cardiovascular drug increases the risk for a serious side effect took top honors at the Department of Clinical Pharmacy...

Improving technologies are rapidly cutting the cost of whole genome sequencing, a process that reveals the complete library of a patient’s genetic information. Indeed, the era of the $1,000 genome—a catchphrase for the test’s relative affordability—appears imminent.

How well do states’ policies address possible conflicts of interest of committee members who decide which drugs get Medicaid reimbursement? The question looms especially large as impending federal health care reform increases the number of patients covered by the state-run drug formularies.

An updated and expanded review of clinical research papers on drugs and medical devices finds that industry-sponsored studies are more likely to lead to favorable results, including reports of greater benefits and fewer harmful side effects.

Systematic reviews seek to answer key questions about the relative effectiveness and safety of medical interventions by selecting, combining, and critically evaluating the research in published medical literature.

Health policy expert Lisa Bero, PhD, is hailed in the latest issue of The Lancet for tackling hot-button subjects such as financial biases in drug research.

Studies of cancer drug dosing in children, possible medication links to delirium in hospital patients, and how to decide when swallowed batteries may call for invasive removal took top honors at the Department of Clinical Pharmacy’s 14th annual Spring Research Seminar.

On March 22 and 23, 2012, the U.S. Food and Drug Administration (FDA) held a public hearing to explore the idea of switching some medications to treat chronic conditions and health emergencies from prescription to over- and behind-the-counter status. Representing a group of academic health...

Harry W. Hind, a 1939 graduate of the UCSF School of Pharmacy who invented solutions that revolutionized contact lens use, as well as a topical patch to treat pain from shingles, died on April 12 at age 96.